Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Biochemical Pharmacology
|
January 15, 1974
Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man
D H Huffman, D W Shoeman, D L Azarnoff
Clinical Pharmacology and Therapeutics
|
November 1, 1977
Digoxin in hyperthyroidism
D H Huffman, C D Klaassen, C R Hartman
Clinical Pharmacology and Therapeutics
|
November 1, 1974
Pharmacokinetics of methotrexate
D L Azarnoff, S H Wan, D H Huffman
Cancer Research
|
November 1, 1977
Metabolic disposition of antipyrine in patients with lung cancer
C Tschanz, C E Hignite, D H Huffman, et al.
American Heart Journal
|
January 1, 1976
Association between clinical cardiac status, laboratory parameters, and digoxin usage
D H Huffman, J W Crow, P Pentikäinen, et al.
Pharmacology
|
January 1, 1973
The effect of spironolactone on antipyrine metabolism in man
D H Huffman, D W Shoeman, P Pentikäinen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1978
Quantitation of N-demethylantipyrine in biological samples and isolation and characterization of its glucuronic acid conjugate
C E Hignite, C Tschanz, D H Huffman, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1977
Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation
F Bochner, D H Huffman, D D Shen, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1973
Pharmacokinetics of methotrexate
D H Huffman, S H Wan, D L Azarnoff, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1978
Gynecomastia induced in normal males by spironolactone
D H Huffman, J P Kampmann, C E Hignite, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Biochemical Pharmacology
|
January 15, 1974
Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man
D H Huffman, D W Shoeman, D L Azarnoff
Clinical Pharmacology and Therapeutics
|
November 1, 1977
Digoxin in hyperthyroidism
D H Huffman, C D Klaassen, C R Hartman
Clinical Pharmacology and Therapeutics
|
November 1, 1974
Pharmacokinetics of methotrexate
D L Azarnoff, S H Wan, D H Huffman
Cancer Research
|
November 1, 1977
Metabolic disposition of antipyrine in patients with lung cancer
C Tschanz, C E Hignite, D H Huffman, et al.
American Heart Journal
|
January 1, 1976
Association between clinical cardiac status, laboratory parameters, and digoxin usage
D H Huffman, J W Crow, P Pentikäinen, et al.
Pharmacology
|
January 1, 1973
The effect of spironolactone on antipyrine metabolism in man
D H Huffman, D W Shoeman, P Pentikäinen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1978
Quantitation of N-demethylantipyrine in biological samples and isolation and characterization of its glucuronic acid conjugate
C E Hignite, C Tschanz, D H Huffman, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1977
Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation
F Bochner, D H Huffman, D D Shen, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1973
Pharmacokinetics of methotrexate
D H Huffman, S H Wan, D L Azarnoff, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1978
Gynecomastia induced in normal males by spironolactone
D H Huffman, J P Kampmann, C E Hignite, et al.
Page
of 5